HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.11
Day range
$0.083 - $0.090
Year range
$0.034 - $0.12
Market cap
15.36M USD
Avg Volume
28.85K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.32M | -11.40% |
Net income | -1.30M | 8.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.38M | -57.63% |
Total assets | 2.51M | -55.90% |
Total liabilities | 3.80M | 2.52% |
Total equity | -1.29M | — |
Shares outstanding | 172.57M | — |
Price to book | -10.88 | — |
Return on assets | -116.45% | — |
Return on capital | 569.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.30M | 8.90% |
Cash from operations | -601.16K | 22.07% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -601.16K | 22.07% |
Free cash flow | -124.50K | 55.10% |
About
Founded
1992
Headquarters
Website
Employees
2
